Stock MRSN MERSANA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Mersana Therapeutics, Inc.

Equities

MRSN

US59045L1061

Real-time Estimate Cboe BZX
Other stock markets
 09:36:24 08/05/2024 pm IST 		5-day change 1st Jan Change
3.425 USD -2.84% Intraday chart for Mersana Therapeutics, Inc. +1.63% +47.63%
20/03 North American Morning Briefing : Markets on Hold -2- DJ
19/03 JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MERSANA THERAPEUTICS, INC. Stock Mersana Therapeutics, Inc.
 431M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 106B
ARGENX SE Stock argenx SE
 23.47B -
BIONTECH SE Stock BioNTech SE
 21.9B -
GENMAB A/S Stock Genmab A/S
 18.77B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 17.85B
  1. Stock Market
  2. Equities
  3. MRSN Stock
  4. Charts Mersana Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW